A detailed history of Thrivent Financial For Lutherans transactions in Eli Lilly & CO stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 427,960 shares of LLY stock, worth $333 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
427,960
Previous 365,582 17.06%
Holding current value
$333 Million
Previous $331 Million 14.55%
% of portfolio
0.72%
Previous 0.67%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $48.2 Million - $59.9 Million
62,378 Added 17.06%
427,960 $379 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $96.8 Million - $121 Million
133,475 Added 57.51%
365,582 $331 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $74 Million - $99 Million
124,984 Added 116.67%
232,107 $181 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $3.65 Million - $4.31 Million
-6,956 Reduced 6.1%
107,123 $62.4 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $2.56 Million - $3.52 Million
-5,878 Reduced 4.9%
114,079 $61.3 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $14.4 Million - $19.2 Million
40,963 Added 51.86%
119,957 $56.2 Million
Q1 2023

May 17, 2023

BUY
$310.63 - $364.82 $240,738 - $282,735
775 Added 0.99%
78,994 $27.1 Million
Q4 2022

Feb 08, 2023

SELL
$321.55 - $374.67 $2.91 Million - $3.39 Million
-9,048 Reduced 10.37%
78,219 $28.6 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $1.04 Million - $1.18 Million
-3,504 Reduced 3.86%
87,267 $28.3 Million
Q2 2022

Aug 16, 2022

SELL
$278.73 - $327.27 $16.3 Million - $19.2 Million
-58,515 Reduced 39.2%
90,771 $29.4 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $1.56 Million - $1.94 Million
-6,637 Reduced 4.26%
149,286 $42.1 Million
Q4 2021

Feb 16, 2022

SELL
$224.85 - $279.04 $9.28 Million - $11.5 Million
-41,257 Reduced 20.92%
155,923 $39.2 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $26,370 - $32,452
-119 Reduced 0.06%
197,180 $45.5 Million
Q2 2021

Sep 24, 2021

BUY
$180.55 - $233.54 $12.9 Million - $16.7 Million
71,400 Added 56.71%
197,299 $45.3 Million
Q2 2021

Aug 19, 2021

SELL
$180.55 - $233.54 $13.7 Million - $17.7 Million
-75,987 Reduced 37.64%
125,899 $28.9 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $8.66 Million - $11.2 Million
-52,716 Reduced 20.71%
201,886 $37.7 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $7.87 Million - $10.4 Million
-60,326 Reduced 19.16%
254,602 $43 Million
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $12.8 Million - $14.8 Million
87,658 Added 38.57%
314,928 $46.6 Million
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $11.9 Million - $14.3 Million
87,077 Added 62.11%
227,270 $35.4 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $6.48 Million - $8.02 Million
54,401 Added 63.41%
140,193 $19.4 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $179,091 - $221,820
-1,675 Reduced 1.92%
85,792 $11.3 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $47,307 - $51,458
443 Added 0.51%
87,467 $9.78 Million
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $6.84 Million - $7.99 Million
-61,755 Reduced 41.51%
87,024 $9.64 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $21.6 Million - $25.5 Million
-194,494 Reduced 56.66%
148,779 $19.3 Million
Q4 2018

Feb 15, 2019

BUY
$105.9 - $118.64 $839,681 - $940,696
7,929 Added 2.36%
343,273 $39.5 Million
Q3 2018

Nov 15, 2018

SELL
$85.86 - $107.31 $863,579 - $1.08 Million
-10,058 Reduced 2.91%
335,344 $36 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $90,234 - $103,560
-1,192 Reduced 0.34%
345,402 $29.5 Million
Q1 2018

May 08, 2018

BUY
$74.21 - $87.6 $15.3 Million - $18.1 Million
206,748 Added 147.84%
346,594 $26.8 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $3.89 Million - $4.17 Million
47,461 Added 51.37%
139,846 $11.8 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $7.12 Million - $7.9 Million
92,385
92,385 $7.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.